Possibility of γδ T cell immunotherapy for HTLV-1-infected individuals

Similar Items

• Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated Neuroinflammatory Disease
  by: Yoshihisa Yamano, et al.
  Published: (2011-08-01)
• The plasticity of HTLV-1 infected CD4+CD25+CCR4+ T-cells through HTLV-1 tax in HAM/TSP
  by: Jacobson Steven, et al.
  Published: (2011-06-01)
• Proteomic profiling of HTLV-1 infected T-cells for the identification of potential biomarkers and therapeutic targets for HTLV-1 associated myelopathy/ tropical spastic paraparesis and adult T-cell leukemia
  by: Nakamura Yusuke, et al.
  Published: (2011-06-01)
• Clinical subtype of HAM/TSP based on clinical course and laboratory findings
  by: Izumo Shuji, et al.
  Published: (2011-06-01)
• CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.
  by: Tomoo Sato, et al.
  Published: (2013-01-01)